Amylyx Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Amylyx Pharmaceuticals's balance sheet done over the years? Its assets were worth $517,454,000 last year, which is more than in the previous period. 16% of Amylyx Pharmaceuticalsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $84,022,000, which means an increase by 65% compared compared to last year.

Debt to Assets

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX): Debt to assets
2019 3220000 28.57M 887.48%
2020 14104000 80.82M 573.09%
2021 105614000 256.78M 243.13%
2022 391453000 50.84M 12.99%
2023 517454000 84.02M 16.24%

AMLX Balance Sheet (2019 โ€“ 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
170.20M62.52M50.19M12.87M3.09M
Short term investments
201.16M284.41M45.92M00
Net receivables
40.05M15.30M000
Inventory
38.32M9.76M000
Other current assets
14.93M10.11M5.39M762K111K
Total current assets
464.66M382.13M101.51M13.63M3.20M
Non-current assets:
Property, Plant and Equipment
6.41M8.13M474K151K0
Goodwill
00000
Intangible assets
00000
Long term investments
0719K189K189K0
Other non-current assets
46.37M465.99K3.44M124.99K18K
Total non-current assets
52.78M9.31M4.10M464.99K18K
Total assets
517.45M391.45M105.61M14.10M3.22M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
00000
Short term debt
4.51M2.04M000
Total current liabilities
82.04M46.60M17.39M7.32M4.52M
Non-current liabilities:
Long term debt
1.98M4.23M01.42M14.93M
Deferred tax
00000
Other non-current liabilities
00239.35M72.06M9.11M
Total non-current liabilities
1.98M4.23M239.38M73.50M24.04M
Total liabilities
84.02M50.84M256.78M80.82M28.57M
Data sourceData sourceData source